MHE State of the Industry survey: The COVID-19 vaccine
In this second of a six-part series, the biggest concern is short supply.
The State of the Industry survey was conducted in October and November before the FDA granted emergency use authorizations for the Pfizer-BioNTech and the Moderna vaccines. Roughly one-third (32%) of the respondents indicated that they were extremely concerned about the vaccine being in short supply, and 41% were indicated that level of concern about a large percentage of American not getting vaccinated.
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
We conducted our annual State of the Industry survey in the early part of November 2023. The survey had 432 respondents, of whom 56% self-reported working for a payer organization (pharmacy benefit manager, insurer or self-insured employer), 34% for a provider organization and the remainder for government or an unspecified “other” category.
Read More
Parity for Mental Health — Any Progress?
October 12th 2023Laws since 1996 have sought to assure that coverage of behavioral health treatments does not take a back seat to physical medicine. Amid a national crisis in mental illness and addiction, that new world of equality has not arrived. But is it on the way?
Read More
